Dr Reddy S Q2fy24 Financial Performance Review

Top Stories

Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read. August 2, 2024 at 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read. August 2, 2024 at 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read. August 2, 2024 at 12:36 PM

Stock chart

Dr. Reddy's Q2FY24 Financial Performance Review

ri-calendar-2-lineOct 27, 2023

By: BlinkX Research Team

FbkFbkTwitterTelegram

In this financial performance review, we delve into the results of Dr. Reddy's for the second quarter of fiscal year 2024 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23(Y-o-Y) % changeQ1FY24(Q-o-Q) % changeQ2FY24
Total Income (₹crs.)6,305.709.116,738.402.16,880.20
Operating Profit (₹crs.)1,612.7010.791,763.601.311,786.70
Net Profit (₹crs.)1,112.8331402.55.531480
Margin (%)17.653.8620.810.7021.51

 

REVENUE: 
Dr. Reddy's reported a total income of ₹6,880.20 crores for Q2FY24, reflecting a stable 2.1% increase compared to the preceding quarter, Q1FY24. On a year-on-year basis, the company showcased a healthy 9.11% growth in total income compared to the same quarter in the previous fiscal year, Q2FY23.

 

OPERATING PROFIT: 
The operating profit for Dr. Reddy's in Q2FY24 was ₹1,786.70 crores, marking a 1.31% increase compared to the preceding quarter, Q1FY24. Year-on-year, the company demonstrated a solid 10.79% growth in operating profit, showcasing efficiency in its operations.

 

NET PROFIT: 
The net profit of Dr. Reddy's for Q2FY24 stood at ₹1,480 crores, displaying a 5.53% increase compared to the preceding quarter, Q1FY24. On a year-on-year basis, the company exhibited significant growth with a remarkable 33% increase in net profit, indicating strong financial performance.

 

MARGINS: 
Dr. Reddy's margin in Q2FY24 was 21.51%, a 0.70% increase compared to the preceding quarter, Q1FY24. Year-on-year, the company significantly improved its margin, with a growth of 3.86%, underlining its focus on profitability and operational excellence.

 

In conclusion, Dr. Reddy's financial performance in Q2FY24 reflects robust growth and an increase in profitability. The company's ability to expand revenue, improve margins, and efficiently manage operating profit is commendable. 

 

Stay tuned for more detailed updates on Dr. Reddy's financial performance in the coming quarters.

Related News

News Thumbnail
Quarterly Result

BLS's Q2FY24 Financial Performance Review

2 mins read. November 6, 2023 at 08:56 AM

News Thumbnail
Quarterly Result

Interglobe Aviation's Q2FY24 Financial Performance Review

2 mins read. November 3, 2023 at 11:31 AM

News Thumbnail
Quarterly Result

Titan's Q2FY24 Financial Performance Review

2 mins read. November 3, 2023 at 10:59 AM

News Thumbnail
Quarterly Result

Zomato's Q2FY24 Financial Performance Review

3 mins read. November 3, 2023 at 09:50 AM

Related Blogs

Stock chartDemat Account

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025

0 people read

3 mins read . Aug 20, 2025

Stock chartMutual Fund

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025

0 people read

8 mins read . Aug 18, 2025

Download app

Access BlinkX
everywhere
across device

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions